Membranous nephropathy in a patient with COVID-19 infection
暂无分享，去创建一个
[1] K. Dilek,et al. Relapse of primary membranous nephropathy after inactivated SARS-CoV-2 virus vaccination , 2021, Kidney International.
[2] S. Nasr,et al. Membranous nephropathy in a patient with coronavirus disease 2019 (COVID-19): A case report , 2021, Clinical nephrology. Case studies.
[3] S. Nasr,et al. Kidney Biopsy Findings in Patients With COVID-19, Kidney Injury, and Proteinuria , 2020, American Journal of Kidney Diseases.
[4] Agati,et al. Kidney Biopsy Findings in Patients with COVID-19. , 2020, Journal of the American Society of Nephrology : JASN.
[5] Sara E. Miller,et al. Visualization of putative coronavirus in kidney , 2020, Kidney International.
[6] S. Rotman,et al. Visualization of putative coronavirus in kidney , 2020, Kidney International.
[7] G. Appel,et al. How COVID-19 Has Changed the Management of Glomerular Diseases. , 2020, Clinical journal of the American Society of Nephrology : CJASN.
[8] Xiaoye Zhu,et al. Renal Phospholipase A2 Receptor in Hepatitis B Virus-Associated Membranous Nephropathy , 2015, American Journal of Nephrology.
[9] E. Messias,et al. Determination of primary versus secondary membranous glomerulopathy utilizing phospholipase A2 receptor staining in renal biopsies , 2013, Modern Pathology.
[10] M. Triggiani,et al. The role of mast cell-derived secreted phospholipases A2 in respiratory allergy. , 2010, Biochimie.